home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

5 rows where docket_id = "FDA-2020-D-0770" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

  • 2021 3
  • 2020 2

document_type 2

  • Other 3
  • Notice 2

agency_id 1

  • FDA 5
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-0770-0006 FDA None FDA-2020-D-0770 Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability; Reopening of the Comment Period Notice Notice of Availability 2021-03-16T04:00:00Z 2021 3 2021-03-16T04:00:00Z 2021-06-15T03:59:59Z 2021-06-15T01:00:39Z 2021-05323 0 0 0900006484a6c6e5
FDA-2020-D-0770-0005 FDA None FDA-2020-D-0770 Supplement from Consumer Healthcare Products Association (CHPA) Other Supplement (SUP) 2021-02-26T05:00:00Z 2021 2 2021-02-26T05:00:00Z   2021-02-26T22:18:33Z   0 0 0900006484a21351
FDA-2020-D-0770-0003 FDA None FDA-2020-D-0770 Request for Extension from Consumer Healthcare Products Association (CHPA) Other Request for Extension 2021-01-11T05:00:00Z 2021 1 2021-01-11T05:00:00Z   2021-01-11T20:28:54Z   0 0 09000064849ea5ba
FDA-2020-D-0770-0002 FDA None FDA-2020-D-0770 Best Practices in Developing Proprietary Names for Non-Prescription Drug Products; Guidance for Industry; Draft Guidance Other Guidance 2020-12-09T05:00:00Z 2020 12 2020-12-09T05:00:00Z 2021-02-09T04:59:59Z 2024-11-06T23:43:04Z   1 0 090000648498f748
FDA-2020-D-0770-0001 FDA None FDA-2020-D-0770 Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability Notice Notice of Availability 2020-12-09T05:00:00Z 2020 12 2020-12-09T05:00:00Z   2021-03-15T21:11:29Z 2020-27057 0 0 090000648498fbf4

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 748.071ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API